XML 95 R6.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash flows from operating activities    
Net income $ 16,568 $ 51,928
Adjustments to reconcile net income to net cash provided by operating activities:    
Amortization of debt issuance costs 792 0
Depreciation and amortization 23,868 14,911
Equity in undistributed earnings of associated companies, net of dividends (129) 2,658
Acquisition-related fair value adjustments related to inventory 10,214 0
Deferred compensation, deferred taxes and other, net (17,204) (898)
Share-based compensation 3,042 2,847
Gain on disposal of property, plant and equipment and other assets (111) (680)
Insurance settlement realized (624) (680)
Combination and other acquisition-related expenses, net of payments (14,218) (349)
Restructuring and related activities (24,045) 0
Pension and other postretirement benefit expense 434 (1,113)
Increase (decrease) in cash from changes in current assets and current liabilities, net of acquisitions:    
Accounts receivable 2,655 (14,029)
Inventories 1,376 (12,719)
Prepaid expenses and other current assets (10,931) 2,196
Restructuring liabilities (4,645) 0
Accounts payable and accrued liabilities 344 6,824
Net cash provided by operating activities 35,476 50,896
Cash flows from investing activities    
Investments in property, plant and equipment (10,112) (8,815)
Payments related to acquisitions, net of cash acquired (798,064) (500)
Proceeds from disposition of assets 75 803
Insurance settlement interest earned 185 102
Net cash used in investing activities (807,916) (8,410)
Cash flows from financing activities    
Proceeds from long-term debt 750,000 0
Borrowings (repayments) on revolving credit facilities, net 85,966 (11,040)
Borrowings (repayments) on other long-term debt, net 415 (478)
Financing-related debt issuance costs (23,747) 0
Dividends paid (15,003) (14,385)
Stock options exercised, other 733 (227)
Distributions to noncontrolling affiliate shareholders 0 (834)
Net cash provided by (used in) financing activities 798,364 (26,964)
Effect of foreign exchange rate changes on cash (1,889) (6,168)
Net increase in cash, cash equivalents and restricted cash 24,035 9,354
Cash, cash equivalents and restricted cash at the beginning of the period 124,425 111,050
Cash, cash equivalents and restricted cash at the end of the period $ 148,460 $ 120,404